Key references: Principles of managing Paget disease of bone

  • Britton C, Walsh J. Paget disease of bone - an update. Aust Fam Physician 2012;41(3):100–3. https://www.ncbi.nlm.nih.gov/pubmed/22396921
  • Ralston SH, Corral-Gudino L, Cooper C, Francis RM, Fraser WD, Gennari L, et al. Diagnosis and management of Paget's disease of bone in adults: a clinical guideline. J Bone Miner Res 2019:e3657. https://www.ncbi.nlm.nih.gov/pubmed/30803025
  • Reid IR, Lyles K, Su G, Brown JP, Walsh JP, del Pino-Montes J, et al. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. J Bone Miner Res 2011;26(9):2261–70. https://www.ncbi.nlm.nih.gov/pubmed/21638319
  • Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, et al. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 2005;353(9):898–908. https://www.ncbi.nlm.nih.gov/pubmed/16135834
  • Singer FR, Bone HG 3rd, Hosking DJ, Lyles KW, Murad MH, Reid IR, et al. Paget's disease of bone: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014;99(12):4408–22. https://www.ncbi.nlm.nih.gov/pubmed/25406796
  • Tan A, Goodman K, Walker A, Hudson J, MacLennan GS, Selby PL, et al. Long-term randomized trial of intensive versus symptomatic management in Paget's disease of bone: The PRISM-EZ study. J Bone Miner Res 2017;32(6):1165–73. https://www.ncbi.nlm.nih.gov/pubmed/28176386